Average Co-Inventor Count = 7.27
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (11 from 3,923 patents)
2. Irm LLC (9 from 151 patents)
3. Chembridge Research Laboratories, Inc. (1 from 1 patent)
16 patents:
1. 11021446 - Compositions and methods for modulating farnesoid X receptors
2. 10683271 - Compositions and methods for modulating farnesoid X receptors
3. 10351576 - Fused tricyclic pyrazole derivatives useful for farnesoid X receptors
4. 10077240 - Compositions and methods for modulating farnesoid X receptors
5. 9682939 - Compositions and methods for modulating farnesoid X receptors
6. 9150568 - Compositions and methods for modulating FXR
7. 8338417 - Compounds and compositions as c-kit and PDGFR kinase inhibitors
8. 8293757 - 5-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
9. 8288540 - 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors
10. 8278452 - Heterocyclic compounds and compositions as c-kit and PDGFR kinase inhibitors
11. 7678792 - Compositions and methods for modulating c-kit and PDGFR receptors
12. 7638523 - Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
13. 7592349 - Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
14. 7563894 - Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
15. 7514447 - Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors